Real World Utilization and Effectiveness of Romosozumab Among Osteoporosis Patients in Hong Kong (20250006)

Study identification

• EU PAS number:
  EUPAS1000000724
• Study ID:
  1000000724
• Official title and acronym:
  Real World Utilization and Effectiveness of Romosozumab Among Osteoporosis Patients in Hong Kong (20250006)
• DARWIN EU® study:
  No
• Study countries:
  China
• Study status:
  Planned

Study timelines

Date when funding contract was signed

Planned:29/08/2025

Study start date

Planned:25/10/2025

Data analysis start date

Planned:19/12/2025

Date of final study report

Planned:31/08/2026

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable